Mithil Patil1, T M Panchanadikar2, Girija Wagh2. 1. Bharati Vidyapeeth University Medical College, Pune, India ; Bharati Hospital & Research Centre, Katraj, Pune, 411043 Maharashtra India. 2. Bharati Vidyapeeth University Medical College, Pune, India.
Abstract
INTRODUCTION: Abnormalities in maternal serum marker levels and fetal measurements obtained during the first trimester screening can be a marker not only for certain chromosomal disorders and anomalies in the fetus but also for specific pregnancy complications. In particular, low maternal serum pregnancy-associated plasma protein-A (PAPP-A), at 11-13 weeks of gestation, is associated with stillbirth, infant death, intrauterine growth restriction, preterm birth, and pre-eclampsia in chromosomally normal fetuses, while a raised nuchal translucency is associated with specific structural abnormalities and genetic syndromes. We have studied the serum Papp-A level in 560 pregnant patients (11-13 weeks gestation) registered at Bharati Hospital and Research Centre, Pune. All patients undergoing testing were followed till the delivery and their neonatal outcome was also taken into consideration. AIMS AND OBJECTIVES: Our aim is to study the pregnancy outcome in relation to the variations of Papp-A level in the first trimester of pregnancy. MATERIALS AND METHODS: Every patient visiting the antenatal OPD was counseled for testing of First Trimester Screening to assess fetal well-being. Patients who were registered for delivery at our hospital were taken into the trial. Blood samples were taken at 11-13 weeks of pregnancy and sent to the PerkinElmer lab for analysis. Results were expressed in Multiple of Median and patients having MOM value less than 0.5 were carefully observed till the delivery, and a thorough neonatal examination was done by a pediatrician. OBSERVATIONS: 524 patients were included in the trial out of which 452 patients were found to have a normal Papp-A level of >0.5 MOM. All these patients were followed further during the antenatal period where 18 patients developed preterm labor and few patients developed pregnancy-induced hypertension. The obstetric outcome of patients with a normal Papp-A level was fairly uneventful as compared to others with a low Papp-A level. CONCLUSIONS: Though Papp-A level in the first trimester of pregnancy (11-13 weeks) is an important predictor of future obstetric outcome, it has poor positive predictive value. Patients having a Papp-A level less than 0.5 MOM have a high risk for preterm delivery, fetal growth restriction, and stillbirths along with increased incidence of hypertensive disorders of pregnancy. A low Papp-A level is a useful indicator of risk of preterm delivery and future chance of development of pregnancy-induced hypertension.
INTRODUCTION: Abnormalities in maternal serum marker levels and fetal measurements obtained during the first trimester screening can be a marker not only for certain chromosomal disorders and anomalies in the fetus but also for specific pregnancy complications. In particular, low maternal serum pregnancy-associated plasma protein-A (PAPP-A), at 11-13 weeks of gestation, is associated with stillbirth, infant death, intrauterine growth restriction, preterm birth, and pre-eclampsia in chromosomally normal fetuses, while a raised nuchal translucency is associated with specific structural abnormalities and genetic syndromes. We have studied the serum Papp-A level in 560 pregnant patients (11-13 weeks gestation) registered at Bharati Hospital and Research Centre, Pune. All patients undergoing testing were followed till the delivery and their neonatal outcome was also taken into consideration. AIMS AND OBJECTIVES: Our aim is to study the pregnancy outcome in relation to the variations of Papp-A level in the first trimester of pregnancy. MATERIALS AND METHODS: Every patient visiting the antenatal OPD was counseled for testing of First Trimester Screening to assess fetal well-being. Patients who were registered for delivery at our hospital were taken into the trial. Blood samples were taken at 11-13 weeks of pregnancy and sent to the PerkinElmer lab for analysis. Results were expressed in Multiple of Median and patients having MOM value less than 0.5 were carefully observed till the delivery, and a thorough neonatal examination was done by a pediatrician. OBSERVATIONS: 524 patients were included in the trial out of which 452 patients were found to have a normal Papp-A level of >0.5 MOM. All these patients were followed further during the antenatal period where 18 patients developed preterm labor and few patients developed pregnancy-induced hypertension. The obstetric outcome of patients with a normal Papp-A level was fairly uneventful as compared to others with a low Papp-A level. CONCLUSIONS: Though Papp-A level in the first trimester of pregnancy (11-13 weeks) is an important predictor of future obstetric outcome, it has poor positive predictive value. Patients having a Papp-A level less than 0.5 MOM have a high risk for preterm delivery, fetal growth restriction, and stillbirths along with increased incidence of hypertensive disorders of pregnancy. A low Papp-A level is a useful indicator of risk of preterm delivery and future chance of development of pregnancy-induced hypertension.
Entities:
Keywords:
Fetal growth restriction; Papp-A in pregnancy; Preterm delivery
Authors: David Krantz; Laura Goetzl; Joe Leigh Simpson; Elizabeth Thom; Julia Zachary; Terrence W Hallahan; Richard Silver; Eugene Pergament; Lawrence D Platt; Karen Filkins; Anthony Johnson; Maurice Mahoney; W Allen Hogge; R Douglas Wilson; Patrick Mohide; Douglas Hershey; Ronald Wapner Journal: Am J Obstet Gynecol Date: 2004-10 Impact factor: 8.661
Authors: E Filippi; J Staughton; E Peregrine; P Jones; W Huttly; D M Peebles; P Pandya; A L David Journal: Ultrasound Obstet Gynecol Date: 2011-05 Impact factor: 7.299
Authors: Jeltsje S Cnossen; Rachel K Morris; Gerben ter Riet; Ben W J Mol; Joris A M van der Post; Arri Coomarasamy; Aeilko H Zwinderman; Stephen C Robson; Patrick J E Bindels; Jos Kleijnen; Khalid S Khan Journal: CMAJ Date: 2008-03-11 Impact factor: 8.262
Authors: L K Proctor; M Toal; S Keating; D Chitayat; N Okun; R C Windrim; G C S Smith; J C P Kingdom Journal: Ultrasound Obstet Gynecol Date: 2009-09 Impact factor: 7.299
Authors: Federica Visconti; Paola Quaresima; Eusebio Chiefari; Patrizia Caroleo; Biagio Arcidiacono; Luigi Puccio; Maria Mirabelli; Daniela P Foti; Costantino Di Carlo; Raffaella Vero; Antonio Brunetti Journal: Int J Environ Res Public Health Date: 2019-09-28 Impact factor: 3.390